Literature DB >> 1276142

Studies on the binding of staphylococcal 125I-labeled alpha-toxin to rabbit erythrocytes.

P Cassidy, S Harshman.   

Abstract

Staphylococcal alpha-toxin, a hemolytic exotoxin, can be iodinated using the lactoperoxidase method. 125 I-Labeled alpha-toxin binds to rabbit erythrocytes in an apparently irreversible and highly specific manner. The binding of 125 I-labeled alpha-toxin to erythrocytes of rabbit and human reflects the species specificity of native alpha-toxin. Binding of 125I-labeled alpha-toxin is blocked by the presence of native alpha-toxin, 127I-labeled alpha-toxin, or anti-alpha-toxin antibody. Simultaneous assays of 125I-labeled alpha-toxin binding and leakage of intracellular 86Rb+ suggest that toxin binding and membrane damage are separate, sequential functions. Both the rate and extent of binding are temperature dependent. Rabbit erythrocytes possess 5 X 10(3) binding sites/cell, while human erythrocytes possess no detectable binding sites. Treatment of rabbit erythrocytes with 125I-labeled alpha-toxin appears to decrease the number of unoccupied binding sites. Chaotropic ions can inhibit 125I-labeled alpha-toxin binding and cause bound 125I-labeled alpha-toxin to dissociate from rabbit erythrocyte membranes. Treatment of intact rabbit erythrocytes with pronase reduces both the binding capacity of the cells for 125I-labeled alpha-toxin, and the cells' sensitivity to hemolysis by native alpha-toxin. It is proposed that the primary binding site for alpha-toxin in biomembranes is a surface membrane protein.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276142     DOI: 10.1021/bi00656a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury.

Authors:  Georgia A Wilke; Juliane Bubeck Wardenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

Review 2.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

3.  Pore formation by Staphylococcus aureus alpha-toxin in lipid bilayers. Dependence upon temperature and toxin concentration.

Authors:  G Belmonte; L Cescatti; B Ferrari; T Nicolussi; M Ropele; G Menestrina
Journal:  Eur Biophys J       Date:  1987       Impact factor: 1.733

Review 4.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

5.  Quantitative analysis of the binding and oligomerization of staphylococcal alpha-toxin in target erythrocyte membranes.

Authors:  J Reichwein; F Hugo; M Roth; A Sinner; S Bhakdi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells.

Authors:  J A Garner; T L Cover
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Histidine residues near the N terminus of staphylococcal alpha-toxin as reporters of regions that are critical for oligomerization and pore formation.

Authors:  R Jursch; A Hildebrand; G Hobom; J Tranum-Jensen; R Ward; M Kehoe; S Bhakdi
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Toxicity of staphylococcal alpha toxin for rabbit alveolar macrophages.

Authors:  M P McGee; A Kreger; E S Leake; S Harshman
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

Review 9.  Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids.

Authors:  Ashley L DuMont; Victor J Torres
Journal:  Trends Microbiol       Date:  2013-11-11       Impact factor: 17.079

10.  Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.

Authors:  S Bhakdi; E Martin
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.